BXLT

Baxalta Incorporated

A maker of medicines for rare diseases, Baxalta produced treatments like ADVATE for hemophilia plus plasma-derived therapies for immunology patients. It was born in 2015 as a spin-off from Baxter International, which kept its medical products while Baxalta took the biopharmaceutical half. The name blends "Bax" from Baxter with the Latin "altus" (meaning "high"), honoring the company's heritage while signaling ambition. Baxalta later joined Shire, which was then absorbed by Takeda.